Showing results (1401-1410 of 1,565) with videos related to

Sort By:
Pageof 157
World Journal of Gastrointestinal Surgery|September 30, 2025
Mesenteric-guided approach to pyloric lymphadenectomy in laparoscopic radical gastrectomyGuo-Feng Pan, Wei-Hong Zhang, Zhi-Ming Cai, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|September 3, 2024
Endo-Lysosomal Network Disorder Reprograms Energy Metabolism in SorL1-Null Rat HippocampusYajie Wang, Yuting Yang, Ying Cai, et al.
Thorax|February 19, 2026
Transcriptomic signatures of IPF in ALI-cultured airway cells and their therapeutic implicationsRobert Lorenz Chua, Carmen Veith, Marc A Schneider, et al.
International Journal of Nanomedicine|January 23, 2019
Nanotubular TiO2 regulates macrophage M2 polarization and increases macrophage secretion of VEGF to accelerate endothelialization via the ERK1/2 and PI3K/AKT pathwaysWei-Chang Xu, Xiao Dong, Jing-Li Ding, et al.
The American Journal of Pathology|June 24, 2005
Regulation of hepatocyte activator inhibitor-1 expression by androgen and oncogenic transformation in the prostateBeatrice S Knudsen, Jared M Lucas, Ladan Fazli, et al.
Biomaterials|March 26, 2025
Autologous tumoral esterase-driven therapeutic polymers sequentially orchestrated antigen-induction, STING activation and anti-angiogenesis for systemic cancer immune therapyNasha Qiu, Chang Xu, Zhen Zhang, et al.
Frontiers in Oncology|June 1, 2022
DHW-221, a Dual PI3K/mTOR Inhibitor, Overcomes Multidrug Resistance by Targeting P-Glycoprotein (P-gp/ABCB1) and Akt-Mediated FOXO3a Nuclear Translocation in Non-small Cell Lung CancerMingyue Liu, Chang Xu, Xiaochun Qin, et al.
European Journal of Pharmacology|August 31, 2024
The efficacy and safety of PI3K and AKT inhibitors for patients with cancer: A systematic review and network meta-analysisYingshi Zhang, Xiangbo Xu, Kaisi Yang, et al.
Frontiers in Oncology|December 6, 2021
Associations Between CAMKK1 Polymorphism rs7214723 and the Prognosis of Patients With Lung CancerHaorui Zhang, Bocen Chen, Zixiu Zou, et al.
Oncogene|July 21, 2021
A pan-cancer analysis of alternative splicing of splicing factors in 6904 patientsRui Cheng, Lixing Xiao, Wenyang Zhou, et al.
Pageof 157